Acta Orthop Belg. 2021 Dec;87(4):705-712. doi: 10.52628/87.4.15.
Repeated joint bleeding leads to chronic synovitis, cartilage damage and bone alterations which result in haemophilic arthropathy and are associated with pain, functional impairment and poor quality of life. There are evidence that Hyaluronic Acid (HA) and Platelet-rich Plasma (PRP) have different mechanisms of action in the treatment of arthropathy for this reason we decided to use both components. The aim of this study is to compare, the efficacy, safety and duration of a single intra-articular injection of PRP against PRP+HA for pain, bleeding episodes and joint health, in the same patient with bilateral hemophilic knee arthropathy. Twenty-one men patients (42 knee joints) were treated with intra- articular injections of PRP or PRP+HA. All of them were haemophilia type A severe. The mean age was 36.6 years (21-72). All patients were evaluated for: Haemophilia Joint Health Score (HJHS), pain (VAS), the number of bleeding episodes (BE) in the last 30 days, before treatment, at three and six months after treatment. Statistically significant improvement were shown for both knee joints at three and six months after treatment for VAS and BE (P < 0.00001). The HJHS score did not significantly improve for either knee in the 6-month period after injection. A single PRP or PRP+HA injection is safe and effective in treating haemophilic arthropathy of the knee for up to 6 months follow-up, reducing pain, bleeding episodes and delaying total knee arthroplasty.
反复关节出血可导致慢性滑膜炎、软骨损伤和骨改变,进而导致血友病性关节病,引起疼痛、功能障碍和生活质量下降。有证据表明,透明质酸 (HA) 和富含血小板的血浆 (PRP) 在治疗关节病方面具有不同的作用机制,因此我们决定同时使用这两种成分。本研究旨在比较单次关节内注射 PRP 与 PRP+HA 治疗双侧血友病性膝关节病患者的疗效、安全性和持续时间。21 名男性患者(42 个膝关节)接受了 PRP 或 PRP+HA 的关节内注射治疗。他们均为重型血友病 A。平均年龄为 36.6 岁(21-72 岁)。所有患者均接受以下评估:血友病关节健康评分(HJHS)、疼痛(VAS)、过去 30 天内的出血事件(BE)次数,治疗前、治疗后 3 个月和 6 个月。治疗后 3 个月和 6 个月时,两种膝关节的 VAS 和 BE 均显示出统计学显著改善(P <0.00001)。注射后 6 个月内,两种膝关节的 HJHS 评分均无显著改善。单次 PRP 或 PRP+HA 注射在治疗血友病性膝关节病方面是安全有效的,可在长达 6 个月的随访期内减轻疼痛、减少出血事件并延缓全膝关节置换术。